Evidence map›Paper›PMID 31953702›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2020

The minimal neuropsychological assessment of MS patients (MACFIMS): normative data of the Italian population.

Paola Grossi, Emilio Portaccio, Fabio Bellomi, Valentina Bianchi, Sabina Cilia, Monica Falautano, Benedetta Goretti, Erika Pietrolongo, Rosa Gemma Viterbo, Michele Messmer Uccelli

Abstract readMulticenter StudyValidation Study
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paola GrossiMS Centre, ASST Crema, Crema, Italy. paolagrossi76@hotmail.com.ORCID http://orcid.org/0000-0003-1581-0623
Emilio PortaccioSOC Neurologia, Ospedale San Giovanni di Dio, AUSL Toscana Centro, Florence, Italy.
Fabio BellomiNeuropsychology Unit, ASST, Spedali Civili di Brescia, Brescia, Italy.
Valentina BianchiAO Sant'Andrea, La Sapienza University, Rome, Italy.
Sabina CiliaASP Catania, Catania, Italy.
Monica FalautanoNeurorehabilitation Unit, San Raffaele Hospital, Milan, Italy.
Benedetta GorettiDepartment NEUROFARBA, Section Neurosciences, University of Florence, Florence, Italy.
Erika PietrolongoDepartment of Neurosciences, Imaging and Clinical Sciences, University G. D'Annunzio, Chieti, Italy.
Rosa Gemma ViterboMS Centre, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Michele Messmer UccelliItalian Multiple Sclerosis Research Foundation, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive impairment is common in multiple sclerosis (MS), and research has emphasized the crucial role of cognitive assessment in disease monitoring. The minimal neuropsychological assessment of MS (MACFIMS) represents one of the neuropsychological batteries most widely used throughout the world. To date, a complete validation, as well as normative values of an alternative form, is lacking in the Italian population, limiting the use of this tool in longitudinal assessment. A total of 200 healthy subjects (127 females and 73 males) were recruited from the community in 8 Italian cities and were evaluated with the MACFIMS at baseline and reassessed with an alternate form of the same battery after 12 months. Regression-based norms that account for demographic influences on test performance were calculated at each time point (baseline and follow-up). The study provides, for the first time, normative values of two forms of the MACFIMS battery for the Italian population. Data application allows clinicians to monitor the performance of cognitive functions over time and to better understand the efficacy of both pharmacological and non-pharmacological interventions in clinical practice and research.

Indexed as

AdolescentAdultAgedCognitive DysfunctionFemaleFollow-Up StudiesHumansItalyMaleMiddle AgedMultiple SclerosisNeuropsychological TestsReference ValuesReproducibility of ResultsYoung AdultCognitive impairmentMultiple sclerosisNeuropsychological batteryNormative data

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.